Furthermore, a Kaplan-Meier analysis showed that ELTD1 overexpression was significantly correlated with poorer disease-free survival (DFS) and overall survival (OS) rates in glioma patients (Fig. 1I–K). This evidence concerns the gene ADGRL4 and glioma.